Skip to main content

Year: 2023

Therapeutic Respiratory Devices Market to Surpass 64.5 Billion by 2030 Drives Due to Surge in Respiratory Disorders

SkyQuest projects that the therapeutic respiratory devices market will attain a USD 64.5 billion value by 2030, with a CAGR of 4% over the forecast period (2023-2030). The global therapeutic respiratory devices market is driven by a surge in respiratory disorders, including COPD and asthma, due to environmental factors and an aging population. This increasing patient pool necessitates advanced therapeutic devices. Westford USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, ongoing innovations in respiratory device technology, such as smart inhalers and portable oxygen concentrators, fuel therapeutic respiratory devices market growth. These advancements improve treatment efficacy, patient compliance, and overall quality of life. Browse In-Depth TOC on the “Therapeutic Respiratory Devices Market”Pages –...

Continue reading

Blood Collection Tubes Market Set to Soar Past USD 10.7 Billion by 2030

The global Blood Collection Tubes market size is expected to reach USD 10.7 billion by 2030 and exhibit a CAGR of 6.50% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for blood tests and diagnostics, growing prevalence of chronic diseases and infectious diseases, rising geriatric population, advancements in healthcare infrastructure and facilities, technological advancements in blood collection tube designs, growing demand for minimally invasive blood collection procedures, are fueling the Market’s growth. Westford, USA, Oct. 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Blood Collection Tubes market, increasing adoption of safety-engineered blood collection tubes, growing demand for vacuum blood collection tubes, rising...

Continue reading

Unifirst Announces Financial Results for the Fourth Quarter and Full Fiscal Year of Fiscal 2023

WILMINGTON, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its fourth quarter and full year ended August 26, 2023, as compared to the corresponding periods in the prior fiscal year: Q4 2023 Financial HighlightsConsolidated revenues for the fourth quarter increased 10.7% to $571.9 million. Operating income was $36.1 million, an increase of 8.5%. The quarterly tax rate increased to 24.3% compared to 21.3% in the prior year. Net income increased to $27.6 million, or 5.5%. Diluted earnings per share increased to $1.47 from $1.39 in the prior year, or 5.8%. EBITDA increased to $69.2 million compared to $60.2 million in the prior year, or 15.0%.The Company’s financial results for the fourth quarters of fiscal 2023 and 2022 included $6.1 million...

Continue reading

GlobalFoundries Awarded $35 Million Funding from U.S. Government to Accelerate Manufacturing of Next-Generation GaN Chips

In partnership with U.S. Government, GF’s semiconductor manufacturing facility in Vermont continues to move closer to large-scale production of next-generation gallium nitride chips for use in aerospace and defense, cellular communications, industrial IoT and automobiles ESSEX JUNCTION, Vt., Oct. 18, 2023 (GLOBE NEWSWIRE) — GlobalFoundries (Nasdaq: GFS) (GF) has been awarded $35 million in federal funding from the U.S. government to accelerate the manufacturing of GF’s differentiated gallium nitride (GaN) on silicon semiconductors at its facility in Essex Junction, Vermont. This funding brings GF closer to large-scale production of GaN chips, which are unique in their ability to handle high voltages and temperatures. These chips are positioned to enable game-changing performance and efficiency in 5G and 6G cellular communications...

Continue reading

Gamer Pakistan Announces Development of Next Generation 5G Edge Mobile Gaming Platform

AI Enhanced Platform to Drive University Esports Worldwide HENDERSON, Nev., Oct. 18, 2023 (GLOBE NEWSWIRE) — Gamer Pakistan Inc. (NASDAQ: GPAK), an early-stage technology and esports company focused on game development and in-game AI community engagement, and organizing esports events in Pakistan, today announced the initiation of development of an esports gaming platform for mobile devices leveraging 4G technology and optimized for 5G, 5G Edge, artificial intelligence (AI) enhancements, and analytics. The 5G Edge platform is expected to launch in phases, the first of which will be the mobile streaming platform and will position Gamer Pakistan as possibly the first mobile gaming company in Pakistan and the Middle East for university/collegiate esports, and streamers. The final platform will include emerging 4K streaming technology...

Continue reading

Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients” to Be Presented at The American College of Gastroenterology (ACG) 2023 Annual Meeting

Selected for a Distinguished Oral Plenary Presentation SOLANA BEACH, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that its real-world healthcare utilization data suggesting reduced healthcare costs for patients on GIMOTI versus patients on oral metoclopramide will be presented, as an oral plenary presentation, at the American College of Gastroenterology annual meeting taking place in Vancouver, BC, Canada from October 20-25, 2023. The authors of the abstract include Richard McCallum, MD (Texas Tech University-El Paso), Michael Cline, DO (Cleveland Clinic) and David Kunkel, MD (University of California, San Diego), which will be presented...

Continue reading

Checkpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer

Cosibelimab is the first PD-L1–blocking antibody to demonstrate a robust, durable and clinically meaningful objective response, and a manageable safety profile, in patients with metastatic cutaneous squamous cell carcinoma Biologics License Application review ongoing; PDUFA goal date of January 3, 2024 WALTHAM, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the publication of results from the multicenter, multiregional, pivotal trial evaluating cosibelimab, a differentiated and potential best-in-class anti-PD-L1 antibody, in patients with metastatic cutaneous squamous cell carcinoma (“cSCC”), in the Journal for ImmunoTherapy of Cancer (JITC), the peer-reviewed, online journal of the Society of Immunotherapy...

Continue reading

Kornit Digital Delivers on Vision of Transforming Industry to On-Demand Sustainable Fashion and Textiles at PRINTING United Expo 2023

Kornit ApolloDemonstrated for the first time at PRINTING United Expo 2023, the game-changing Kornit Apollo platform – offering the ultimate in high-throughput digital production at scale.Kornit PrestoVisit Kornit Digital at PRINTING United Expo 2023 at Booth C1322 for a closer look at the enhanced Kornit Presto MAX – a single-step solution transforming virtual concepts into brilliant custom fabrics for fashion, home decor, and key textile applications.Kornit Atlas MAX PolyLive demonstrations at PRINTING United Expo include the revolutionary Atlas MAX POLY – transforming professional and recreational sportswear, teamwear and licensed gear to inject new life into apparel with unmatched design freedom.Company Operations Remain Strong and Unified Across Customers, Partners and Team Members Despite...

Continue reading

Workhorse Group Advances Aero Business

Progresses Industry and FAA Collaboration Company Awarded Two Additional USDA Grants CINCINNATI, Oct. 18, 2023 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero emission commercial vehicles, today announced significant progress it is making in advancing Workhorse Aero, the Company’s drone business. “We are making important progress with our Aero Business, and the steps we are highlighting today reflect the strength of our technology, our systems and our people,” said Rick Dauch, Workhorse CEO. “We have clear growth strategies, and our team is focused on capturing the tremendous opportunities as we work to make last mile delivery more sustainable and more efficient.” John Graber, Workhorse Aero President, said, “Our Aero...

Continue reading

GSI Technology Announces Tape-Out of the Gemini-II APU

SUNNYVALE, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), developer of the Gemini® Associative Processing Unit (APU) for AI and high-performance computing (HPC) and a leading provider of high-performance memory solutions for the networking, telecommunications, and military markets, today announced tape-out of the Gemini-II Associated Processing Unit, its second generation of the groundbreaking and patented compute-in-memory APU family, on TSMC’s 16nm process. Gemini-II will bring significant performance enhancements over Gemini-I with more than ten times the processing performance with eight times the memory density compared to Gemini-I. These upgrades provide 184 TOPS (8bit adds) and more than 5.8 Peta OPS for Boolean operations at 1.4GHz operation. Gemini-II’s combination of high processing power,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.